SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-073679
Filing Date
2012-11-02
Accepted
2012-11-02 16:06:36
Documents
13
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20021_110q.htm 10-Q 822008
2 EX-10.1 a12-20021_1ex10d1.htm EX-10.1 16185
3 EX-10.2 a12-20021_1ex10d2.htm EX-10.2 42874
4 EX-31.1 a12-20021_1ex31d1.htm EX-31.1 10614
5 EX-31.2 a12-20021_1ex31d2.htm EX-31.2 10744
6 EX-32 a12-20021_1ex32.htm EX-32 7607
13 GRAPHIC g200211kei001.jpg GRAPHIC 3395
  Complete submission text file 0001104659-12-073679.txt   6587088

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT optr-20120930.xml EX-101.INS 787611
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optr-20120930.xsd EX-101.SCH 64315
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT optr-20120930_cal.xml EX-101.CAL 54617
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT optr-20120930_def.xml EX-101.DEF 311957
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT optr-20120930_lab.xml EX-101.LAB 996925
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optr-20120930_pre.xml EX-101.PRE 430344
Mailing Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302 (201) 333-8819
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33291 | Film No.: 121176865
SIC: 2834 Pharmaceutical Preparations